FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) submitted by Sandoz Inc, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• LESCOL XL (Fluvastatin sodium)

Snippet

SUPPL AP for LESCOL XL (FLUVASTATIN SODIUM)